Subcortical ischaemic vascular dementia

Lancet Neurology

Volumn 1, Issue 7, 2002, Pages 426-436

  Román, Gustavo C ^a,e   Erkinjuntti, Timo ^b   Wallin, Anders ^c   Pantoni, Leonardo ^f   Chui, Helena C ^d  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d RANCHO LOS AMIGOS NATIONAL REHABILITATION CENTER   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CITALOPRAM; CITICOLINE; CYCLANDELATE; DONEPEZIL; GALANTAMINE; GINKGO BILOBA EXTRACT; MEMANTINE; NICERGOLINE; NICOTINIC ACID; NIMODIPINE; OLANZAPINE; OXIRACETAM; PAPAVERINE; PENTOXIFYLLINE; PIRACETAM; PROPENTOFYLLINE; RISPERIDONE; RIVASTIGMINE; SERTRALINE; TRIFLUSAL;

ALZHEIMER DISEASE; AUTOREGULATION; BASAL GANGLION; BLOOD RHEOLOGY; BRAIN CAPILLARY; BRAIN CORTEX; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN OXYGEN CONSUMPTION; BRAIN PERFUSION; BRAIN VENTRICLE; CEREBRAL ARTERY DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DISEASE MARKER; DRUG SCREENING; DYSARTHRIA; EPIDEMIOLOGICAL DATA; FIBRINOGEN BLOOD LEVEL; GAIT DISORDER; GENETIC ANALYSIS; HEART ARRHYTHMIA; HEREDITY; HIGH RISK POPULATION; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; LEUKOENCEPHALOPATHY; MICROANGIOPATHY; MOOD DISORDER; MOTOR DYSFUNCTION; MULTIINFARCT DEMENTIA; NEUROCHEMISTRY; NEUROPATHOLOGY; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENESCENCE; SLEEP APNEA SYNDROME; SMOKING; SYMPTOM; THALAMOCORTICAL TRACT; URINARY DYSFUNCTION; VASCULAR AMYLOIDOSIS; WHITE MATTER; BRAIN; BRAIN CIRCULATION; MYELINATED NERVE; PATHOLOGY; PHYSIOLOGY; PREVALENCE; VASCULARIZATION;

BRAIN; BRAIN ISCHEMIA; CEREBRAL INFARCTION; CEREBROVASCULAR CIRCULATION; DEMENTIA, VASCULAR; HUMANS; NERVE FIBERS, MYELINATED; PREVALENCE; RISK FACTORS;

EID: 0038049283     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(02)00190-4     Document Type: Review

References (152)

1. Dubois M.F., Herbert R. The incidence of vascular dementia in Canada: a comparison with Europe and East Asia. Neuroepidemiology. 20:2001;179-187.
2. Brun A. The neuropathology of vascular dementia. Chiu E., Gustafson L., Ames D., Folstein M.F. Cerebrovascular disease and dementia. 2000;69-76 Martin Dunitz, London.
3. Pryse-Phillips W. Companion to clinical neurology. 1995;Little, Brown and Company, Boston.
4. Chui H. Dementia due to subcortical ischaemic vascular disease. Clin Cornerstone. 3:2001;40-51.
5. Sacco S.E., Whisnant J.P., Broderick J.P., Phillips S.J., O'Fallon W.M. Epidemiological characteristics of lacunar infarcts in a population. Stroke. 22:1991;1236-1241.
6. Saposnik G., González L., Lepera S., et al. Southern Buenos Aires stroke project. Acta Neurol Scand. 104:2001;130-135.
7. Lee B.I., Nam H.S., Heo J.H., Kim D.I. Yonsei Stroke Registry: analysis of 1000 patients with acute cerebral infarctions. Cerebrovasc Dis. 12:2001;145-151.
8. Fisher C.M. Lacunes: small deep cerebral infarcts. Neurology. 15:1965;774-784.
9. Shinkawa A., Ueda K., Kiyohara Y., et al. Silent cerebral infarction in a community-based autopsy series in Japan: the Hisayama Study. Stroke. 26:1995;380-385.
10. Longstreth W.T. Jr, Bernick C., Manolio T., Bryan N., Jungreis C.A., Price T.R. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol. 55:1998;1217-1225.
11. Kase C.S., Wolf P.A., Chodosh E.H., et al. Prevalence of silent stroke in patients presenting with initial stroke: the Framingham Study. Stroke. 20:1989;850-852.
12. Giroud M., Gras P., Milan C., et al. Natural history of lacunar syndromes: contribution of the Dijon registry of cerebrovascular complications. Rev Neurol (Paris). 147:1991;566-572.
13. Vermeer S.E., Koudstaal P.J., Oudkerk M., Hofman A., Breteler M.M. Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke. 33:2002;21-25.
14. Longstreth W.T. Jr, Manolio T., Arnold A., et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: the Cardiovascular Health Study. Stroke. 27:1996;1274-1282.
15. Breteler M.M.B., van Swieten J.C., Bots M.L., et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology. 44:1994;1246-1252.
16. Ylikoski A., Erkinjuntti T., Raininko R., Sarna S., Sulkava R., Tilvis R. White matter hyperintensities on the MRI in the neurologically non-demented elderly: analysis of cohorts of consecutive subjects aged 65 to 85 years living at home. Stroke. 26:1995;11781-11787.
17. Lindgren A., Roijer A., Rudling O., et al. Cerebral lesions on magnetic resonance imaging, heart disease, and vascular risk factors in subjects without stroke: a population-based study. Stroke. 25:1994;929-934.
18. Liao D., Cooper L., Cai J., et al. The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular risk factors: the ARIC study. Neuroepidemiology. 16:1997;149-162.
19. Román G.C. From UBOs to Binswanger's disease: impact of magnetic resonance imaging on vascular dementia research. Stroke. 27:1996;1269-1273.
20. de Groot J.C., de Leeuw F.E., Oudkerk M., Hofman A., Jolles J., Breteler M.M. Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam Scan Study. Neurology. 56:2001;1539-1545.
21. Guo X., Skoog I., Matousek M., et al. A population-based study on motor performance and white matter lesions in older women. J Am Geriatr Soc. 48:2000;967-970.
22. Englund E.A., Person B. Correlations between histopathologic white matter changes and proton MR relaxation times in dementia. Alzheimer Dis Assoc Disord. 1:1987;156-170.
23. Román G.C. Senile dementia of the Binswanger type: a vascular form of dementia in the elderly. JAMA. 258:1987;1782-1788.
24. Vinters H.V., Ellis W.G., Zarow C., et al. Neuropathological substrate of ischemic vascular dementia. J Neuropathol Exp Neurol. 59:2000;931-945.
25. Garcia J.H., Lassen N.A., Weiller C., Sperling B., Nakagawara J. Ischemic stroke and incomplete infarction. Stroke. 27:1996;761-765.
26. Pantoni L., Garcia J.H., Gutierrez J.A. Cerebral white matter is highly vulnerable to ischemia. Stroke. 27:1996;1641-1647.
27. Tomonaga M., Yamanouchi H., Tohgi H., Kameyama M. Clinicopathologic study of progressive subcortical vascular encephalopathy (Binswanger type) in the elderly. J Am Geriatr Soc. 30:1982;524-529.
28. Ferrer I., Bella R., Serrano M.T., Marti E., Guionnet N. Arteriolosclerotic leucoencephalopathy in the elderly and its relation to white matter lesions in Binswanger's disease, multi-infarct encephalopathy and Alzheimer's disease. J Neurol Sci. 99:1990;37-50.
29. Pantoni L., García J.H. The significance of cerebral white matter abnormalities 100 years after Binswanger's report: a review. Stroke. 26:1995;1293-1301.
30. de la Torre J.C., Fortin T., Park G.A.S., et al. Chronic cerebrovascular insufficiency induces dementia-like deficits in aged rats. Brain Res. 582:1992;186-195.
31. Tanaka K., Wada N., Hori K., Asanuma M., Nomura M., Ogawa N. Chronic cerebral hypoperfusion disrupts discriminative behavior in acquired-learning rats. J Neurosci Methods. 84:1998;63-68.
32. Naritomi H. Experimental basis of multi-infarct dementia: memory impairments in rodent models of ischemia. Alzheimer Dis Assoc Disord. 5:1991;103-111.
33. Kudoh T., Takeda M., Tanimukai S., Nashimura T. Neuropathologic changes in the gerbil brain after chronic hypoperfusion. Stroke. 24:1993;259-265.
34. Tanaka K., Wada N., Ogawa N. Chronic cerebral hypoperfusion induces transient reversible monoaminergic changes in the rat brain. Neurochem Res. 25:2000;313-320.
35. Hattori H., Takeda M., Kudo T., et al. Cumulative white matter changes in the gerbil brain under chronic cerebral hypoperfusion. Acta Neuropathol. 84:1992;437-442.
36. Caplan L.R. Binswanger's disease revisited. Neurology. 45:1995;626-633.
37. Schneider R., Ringelstein E.B., Zeumer H., KJiesewetter H., Jung F. The role of plasma hyperviscosity in subcortical arteriosclerotic encephalopathy (Binswanger's disease). J Neurol. 234:1987;67-73.
38. Strandgaard S., Paulson O.B. Regulation of cerebral blood flow in health and disease. J Cardiovasc Pharmacol. 19:(suppl):1992;S89-S93.
39. Baron J.C. Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications. Cerebrovasc Dis. 11:(suppl 1):2001;2-8.
40. DeReuck J., Decoo D., Hasenbroekx M.C., et al. Acetazolamide vasoreactivity in vascular dementia: a positron emission tomographic study. Eur Neurol. 41:1999;31-36.
41. 2O positron emission tomography. Stroke. 26:1995;1825-1829.
42. Yao H., Sadoshima S., Kuwabara Y., et al. Cerebral blood flow and oxygen metabolism in patients with vascular dementia of the Binswanger type. Stroke. 21:1990;1694-1699.
43. Nakane H., Ibayashi S., Fujii K., et al. Cerebral blood flow and metabolism in patients with silent brain infarction: occult misery perfusion in cerebral cortex. J Neurol Neurosurg Psychiatry. 65:1998;317-321.
44. Fein G., Di Sclafani V., Tanabe J., et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology. 55:2000;1626-1635.
45. Mungas D., Jagust W.J., Reed B.R., et al. MRI predictors in subcortical ischemic vascular disease and Alzheimer's disease. Neurology. 57:2001;2229-2235.
46. Pohjasvaara T., Mantyla R., Salonen O., et al. How complex interaction of ischemic brain infarcts, white matter lesions and atrophy relate to post-stroke dementia. Arch Neurol. 57:2000;1295-1300.
47. Furuta A., Ishii N., Nishihara Y., Horie A. Medullary arteries in aging and dementia. Stroke. 22:1991;442-446.
48. Alex M., Baron E.K., Goldenberg S., Blumenthal H.T. An autopsy study of cerebrovascular accident in diabetes mellitus. Circulation. 25:1962;663-673.
49. Bertsch T., Mielke O., Holy S., et al. Homocysteine in cerebrovascular disease: an independent risk factor for subcortical vascular encephalopathy. Clin Chem Lab Med. 39:2001;721-724.
50. Ravens J.R. Vascular changes in the human senile brain. Adv Neurol. 20:1978;487-501.
51. Duvernoy H.M., Delon S., Vanson J.L. Cortical blood vessels of the human brain. Brain Res Bull. 7:1981;519-579.
52. Román G.C. Vascular dementia. Fisher M. Clinical atlas of cerebrovascular disorders. 1994;13.1-13.23 Wolfe/Mosby-Year Book Europe, London.
53. Klassen A.C., Sung J.H., Stadlan E.M. Histological changes in cerebral arteries with increasing age. J Neuropathol Exp Neurol. 27:1968;607-623.
54. Akima M., Nonaka H., Kagesawa M., Tanaka K. A study on the microvasculature of the cerebral cortex. Lab Invest. 55:1986;482-489.
55. Okeda R. Morphometrische Vergleichsuntersuchungen an Hirnarterien bei Binswangerscher Encephalopathie und Hochdruckencephalopathie. Acta Neuropathol (Berl). 26:1973;23-43.
56. Moody D.M., Bell M.A., Challa V.R. The corpus callosum, a unique white-matter tract: anatomic features that may explain sparing in Binswanger disease and resistance to flow of fluid masses. AJNR Am J Neuroradiol. 9:1988;1051-1059.
57. van Swieten J.C., van Den Hout J.H.W., van Ketel B.A., Hijdra A., Wokke J.H.J., van Gijn J. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly: a morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain. 114:1991;761-774.
58. Fisher C.M. The arterial lesions underlying lacunes. Acta Neuropathol (Berl). 12:1969;1-15.
59. Cervós-Navarro J., Matakas F., Roggendorf W., Christmann U. The morphology of spastic intracerebral arterioles. Neuropathol Appl Neurobiol. 4:1978;369-379.
60. Erkinjuntti T., Benavente O., Eliasziw M., et al. Diffuse vacuolization (spongiosis) and arteriolosclerosis in the frontal white matter occurs in vascular dementia. Arch Neurol. 53:1996;325-332.
61. Pantoni L., Garcia J.H. Pathogenesis of leukoaraiosis: a review. Stroke. 28:1997;652-659.
62. Révész T., Hawkins C.P., du Boulay E.P.G.H., Barnard R.O., McDonald W.I. Pathological findings correlated with magnetic resonance imaging in subcortical arteriosclerotic encephalopathy (Binswanger's disease). J Neurol Neurosurg Psychiatry. 52:1989;1337-1344.
63. Gray F., Dubas F., Roullet E., Escourolle R. Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy. Ann Neurol. 18:1985;54-59.
64. Smith E.E., Rosand J., Knudsen K.A., Hylek E.M., Greenberg S.M. Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke. Neurology. 59:2002;193-197.
65. Moody D.M., Brown W.R., Challa V.R., Anderson R.L. Periventricular venous collagenosis: association with leukoaraiosis. Radiology. 194:1995;469-476.
66. Sze G., De Armond S.J., Brant-Zawadzki M., Davis R.L., Norman D., Newton T.H. Foci of MRI signal (pseudolesions) anterior to the frontal horns: histologic correlations of a normal finding. AJNR Am J Neuroradiol. 7:1986;381-387.
67. Olsson Y., Brun A., Englund E. Fundamental pathological lesions in vascular dementia. Acta Neurol Scand. 68:(suppl 1):1996;31-38.
68. Uggetti C., Egitto M.G., Pichiecchio A., et al. Subcortical dementia associated with striking enlargement of the Virchow-Robin spaces and transneural degeneration of the left mammillo-thalamic tract. Cerebrovasc Dis. 12:2001;287-290.
69. Vital C., Julien J. Widespread dilatation of perivascular spaces: a leukoencephalopathy causing dementia. Neurology. 48:1997;1310-1333.
70. Capizzano A.A., Schuff N., Amend D.L., et al. Subcortical ischemic vascular dementia: assessment with quantitative MR imaging and H1 MR spectroscopy. AJNR Am J Neuroradiol. 21:2000;621-630.
71. Pantoni L., Inzitari D., Pracucci G., et al. Cerebrospinal fluid proteins in patients with leucoaraiosis: possible abnormalities in blood-brain barrier function. J Neurol Sci. 115:1993;125-131.
72. Wallin A., Sjogren M., Edman A., Blennow K., Regland B. Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia. Eur Neurol. 44:2000;229-235.
73. Akiguchi I., Tomimoto H., Suenaga T., Wakita H., Budka H. Alterations in glia and axons in the brains of Binswanger's disease patients. Stroke. 28:1997;1423-1429.
74. Akiguchi I., Tomimoto H., Suenaga T., Wakita H., Budka H. Blood-brain barrier dysfunction in Binswanger's disease: an immunohistochemical study. Acta Neuropathol (Berl). 95:1998;78-84.
75. Tarkowski E., Issa R., Sjogren M., et al. Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. Neurobiol Aging. 23:2002;237-243.
76. Tarkowski E., Wallin A., Regland B., Blennow K., Tarkowski A. Local and systemic GM-CSF increase in Alzheimer's disease and vascular dementia. Acta Neurol Scand. 103:2001;166-174.
77. Tarkowski E., Blennow K., Wallin A., Tarkowski A. Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent in Alzheimer's disease and vascular dementia. J Clin Immunol. 19:1999;223-230.
78. Tournier-Lasserve E., Joutel A., Melki J., et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet. 3:1993;256-259.
79. Joutel A., Vahedi K., Corpechor C., et al. Strong clustering and stereotyped nature of mutations in CADASIL patients. Lancet. 350:1997;1511-1515.
80. Dichgans M., Herzog J., Gasser T. Notch3 mutation involving three cysteine residues in a family with typical CADASIL. Neurology. 57:2001;1714-1717.
81. Ruchoux M.M., Guerouaou D., Vandenhaute B., et al. Systemic vascular smooth muscle impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol (Berl). 89:1995;500-512.
82. Joutel A., Favrole P., Labauge P., et al. Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis. Lancet. 358:2001;2049-2051.
83. Bruening R., Dichgans M., Berchtenbreiter C., et al. CADASIL: decrease in regional rCBV in hyperintense subcortical lesions inversely correlates with disability and cognitive performance. AJNR Am J Neuroradiol. 22:2001;1268-1274.
84. Vinters H.V. Cerebral amyloid angiopathy: a microvascular link between parenchymal and vascular dementia? Ann Neurol. 49:2001;691-693.
85. Natte R., Maaat-Schieman M.L., Haan J., Bornebroek M., Roos R.A., van Duinen S.G. Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Ann Neurol. 50:2001;765-772.
86. Mead S., James-Galton M., Revesz T., et al. Familial British dementia with amyloid angiopathy: early clinical, neuropsychological and imaging findings. Brain. 123:2000;975-991.
87. Markus H.S., Barley J., Lunt R., et al. Angiotensin-converting enzyme gene deletion polymorphism: a new risk factor for lacunar stroke but not carotid atheroma. Stroke. 26:1995;1329-1333.
88. Schmidt R., Schmidt H., Fazekas F., et al. MRI cerebral white matter lesions and paraoxonase PON1 polymorphisms: three-year follow-up of the Austrian Stroke Prevention Study. Arterioscler Thromb Vasc Biol. 20:2000;1811-1816.
89. Fassbender K., Mielke O., Bertsch T., Nafe B., Froschen S., Hennerici M. Homocysteine in cerebral macroangiopathy and microangiopathy. Lancet. 353:1999;1586-1587.
90. Bronge L., Fernaeus S.-E., Blomberg M., et al. White matter lesions in Alzheimer patients are influenced by apolipoprotein E genotype. Dement Geriatr Cogn Disord. 10:1999;89-96.
91. Román G.C., Royall D.R. Executive control function: a rational basis for the diagnosis of vascular dementia. Alzheimer Dis Assoc Disord. 13:(suppl 3):1999;S69-S80.
92. Ishii N., Nishihara Y., Imamura T. Why do frontal lobe symptoms predominate in vascular dementia with lacunes? Neurology. 36:1986;340-345.
93. Wolfe N., Linn R., Babikian V.L., et al. Frontal systems impairment following multiple lacunar infarcts. Arch Neurol. 47:1990;129-132.
94. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci. 9:1986;137-181.
95. Cummings J.L. Frontal-subcortical circuits and human behavior. Arch Neurol. 50:1993;873-880.
96. Mega M.S., Cummings J.L. Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci. 6:1994;358-370.
97. Grigsby J., Kaye K., Shetterly S.M., Baxter J., Morgenstern N.E., Hamman R.F. Prevalence of disorders of executive cognitive functioning among the elderly: findings from the San Luis Valley Health and Aging Study. Neuroepidemiology. 21:2002;213-220.
98. Folstein M.F., Folstein S.E., McHugh P.R. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 12:1975;189-198.
99. Huppert F.A., Brayne C., Gill C., Paykel E.S., Beardsall L. CAMCOG: a concise neuropsychological test to assist dementia diagnosis: sociodemographic characteristics in an elderly population sample. Br J Clin Psychol. 34:1995;529-541.
100. Wallin A., Blennow K., Gottfries C.G. Subcortical symptoms predominate in vascular dementia. Int J Geriatr Psychiatry. 6:1991;137-146.
101. Wallin A., Edman A., Blennow K., et al. Stepwise comparative status analysis (STEP): a tool for the identification of regional brain syndromes in dementia. J Geriatr Psychiatry Neurol. 4:1996;185-199.
102. Royall D.R. Executive cognitive impairment: a novel perspective on dementia. Neuroepidemiology. 19:2000;293-299.
103. Tatemichi T.K., Desmont D.W., Prohovnik I., et al. Strategic infarcts in vascular dementia: a clinical and imaging experience. Arzneimittel-Forschung/Drug Research. 45:1995;371-385.
104. Pantoni L., Basile A.M., Romanelli M., et al. Abulia and cognitive impairment in two patients with capsular genu infarct. Acta Neurol Scand. 104:2001;185-190.
105. Castaigne P., Buge A., Cambier J., et al. Démence thalamique d'origine vasculaire par ramollissement bilatéral, limité au territoire du péduncule retromamillaire: a propos de deux observations anatomo-cliniques. Rev Neurol (Paris). 114:1966;89-107.
106. Caplan L.R., Schmahmann J.D., Kase C.S., et al. Caudate infarcts. Arch Neurol. 47:1990;133-143.
107. Chukwudelunzu F.E., Meschia J.F., Graff-Radford N.R., Lucas J.A. Extensive metabolic and neuropsychological abnormalities associated with discrete infarction of the genu of the internal capsule. J Neurol Neurosurg Psychiatry. 71:2001;658-662.
108. Tierney M.C., Black S.E., Szalai J.P., et al. Recognition memory and verbal fluency differentiate probable Alzheimer disease from subcortical ischemic vascular dementia. Arch Neurol. 58:2001;1654-1659.
109. Kramer J.H., Reed B.R., Mungas D., Weiner M.W., Chui H.C. Executive dysfunction in subcortical ischaemic vascular disease. J Neurol Neurosurg Psychiatry. 72:2002;217-220.
110. Alexopoulos G.S., Kiosses D.N., Klimstra S., Kalayam B., Bruce M.L. Clinical presentation of the 'depression-executive dysfunction syndrome' of late life. Am J Geriatr Psychiatry. 10:2002;98-106.
111. Bazner H., Oster M., Daffertshofer M., Hennerici M. Assessment of gait in subcortical vascular encephalopathy by computerized analysis: a cross-sectional and longitudinal study. J Neurol. 247:2000;841-849.
112. Foltynie T., Barker R., Brayne C. Vascular parkinsonism: a review of the precision and frequency of the diagnosis. Neuroepidemiology. 21:2002;1-7.
113. Richert A., Ansarin K., Baran A.S. Sleep apnea and hypertension: pathophysiologic mechanisms. Semin Nephrol. 22:2002;71-77.
114. Zuccalà G., Onder G., Pedone C., et al. Hypotension and cognitive impairment: selective association in patients with heart failure. Neurology. 57:2001;1986-1992.
115. Pullicino P.M., Hart J. Cognitive impairment in congestive heart failure? Embolism vs hypoperfusion. Neurology. 57:2001;1945-1946.
116. de Leeuw F.E., de Groot J.C., Ouderk M., et al. Atrial fibrillation and the risk of cerebral white matter lesions. Neurology. 54:2000;1795-1801.
117. Guo Z., Viitanen M., Fratiglioni L., Winblad B. Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ. 312:1996;805-808.
118. Mendez G.F., Cowie M.R. The epidemiological features of heart failure in developing countries: a review of the literature. Int J Cardiol. 80:2001;213-219.
119. Pullicino P., Mifsud V., Wong E., Graham S., Ali I., Smajlovic D. Hypoperfusion-related cerebral ischemia and cardiac left ventricular systolic dysfunction. J Stroke Cerebrovasc Dis. 10:2001;178-182.
120. Barclay L.L., Weiss E.M., Mattis S., Bond O., Blass J.P. Unrecognized cognitive impairment in cardiac rehabilitation patients. J Am Geriatr Soc. 36:1988;22-28.
121. McKhann G.M., Goldsborough M.A., Borowicz L.M. Jr, et al. Cognitive outcome after coronary artery bypass: a one-year prospective study. Ann Thorac Surg. 63:1997;510-515.
122. Newman M.F., Kirchner J.L., Phillips-Bute B., et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 344:2001;395-402.
123. Abildstrom H., Rasmussen L.S., Rentowl P., et al. Cognitive dysfunction 1-2 years after non-cardiac surgery in the elderly: International Study of Post-Operative Cognitive Dysfunction. Acta Anaesthesiol Scand. 44:2000;1246-1251.
124. Cree M., Carriere K.C., Soskolne C.L., Suarez-Almazor M. Functional dependence after hip fracture. Am J Phys Med Rehabil. 80:2001;736-743.
125. Looi J.C., Sachdev P.S. Differentiation of vascular dementia from AD on neuropsychological tests. Neurology. 53:1999;670-678.
126. Royall D.R., Cordes J.A., Polk M. CLOX: an executive drawing task. J Neurol Neurosurg Psychiatry. 64:1998;588-594.
127. Luria A.R. Higher cortical functions in man. 1966;Basic Books, New York.
128. Royall D.R., Mahurin R.K., Gray K.F. Bedside assessment of executive cognitive impairment: the executive interview. J Am Geriatr Soc. 40:1992;1221-1226.
129. Ferris S. Cognitive outcome measures for VaD. Alzheimer Dis Assoc Disord. 13:(suppl 3):1999;S140-S143.
130. van Swieten J.C., Hijdra A., Koudstaal P.J., van Gijn J. Grading white matter lesions on CT and MRI: a simple scale. J Neurol Neurosurg Psychiatry. 53:1990;1080-1083.
131. Wahlund L.O., Barkhof F., Fazekas F., et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 32:2001;1318-1322.
132. Mantyla R., Erkinjuntti T., Salonen O., et al. Variable agreement between visual rating scales for white matter hyperintensities on MRI: comparison of 13 rating scales in a post-stroke cohort. Stroke. 28:1997;1614-1623.
133. Scheltens P., Erkinjunti T., Leys D., et al. White matter changes on CT and MRI: an overview of visual rating scales: European Task Force on Age-Related White Matter Changes. Eur Neurol. 39:1998;80-89.
134. Jagust W. Untangling vascular dementia. Lancet. 358:2001;2097-2098.
135. Sarangi S., San Pedro E.C., Mountz J.M. Anterior choroidal artery infarction presenting as a progressive cognitive deficit. Clin Nucl Med. 25:2000;187-1890.
136. Moroney J.T., Bagiella E., Desmond D.W., et al. Meta-analysis of the Hachinski ischemic score in pathologically verified dementias. Neurology. 49:1997;1096-1105.
137. Hénon H., Durieu I., Guerouaou D., et al. Post-stroke dementia: incidence and relationship to pre-stroke cognitive decline. Neurology. 57:2001;1216-1222.
138. Bennett D.A., Wilson R.S., Schneider J.A., et al. Natural history of mild cognitive impairment in older persons. Neurology. 59:2002;198-205.
139. de la Torre J.C. Alzheimer disease as a vascular disorder. Stroke. 23:2002;1152-1162.
140. Snowdon D.A., Greiner L.H., Mortimer J.A., et al. Brain infarction and the clinical expression of Alzheimer's disease: the Nun Study. JAMA. 277:1997;813-817.
141. Du A.T., Schuff N., Laakso M.P., et al. Effects of subcortical ischemic vascular dementia on AD on entorhinal cortex and hippocampus. Neurology. 58:2002;1635-1641.
142. Wallin A., Sjögren M. CSF cytoskeleton proteins in patients with subcortical white-matter dementia. Mech Ageing Dev. 122:2001;1937-1949.
143. Erkinjuntti T., Inzitari D., Pantoni L., et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transmission. 59:(suppl 1):2000;23-30.
144. Román G.C., Tatemichi T.K., Erkinjuntti T., et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology. 43:1993;250-260.
145. Birkenhager W.H., Forette F., Seux M.L., et al. Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension. Arch Intern Med. 161:2001;152-156.
146. Jick H., Zornberg G.L., Jick S.S., Seshadri S., et al. Statins and the risk of dementia. Lancet. 356:2000;1627-1631.
147. Román G.C. Perspectives in the treatment of vascular dementia. Drugs Today. 36:2000;641-653.
148. Pantoni L., Rossi R., Inzitari D., et al. Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial. J Neurol Sci. 175:2000;124-134.
149. Orgogozo J.M., Rigaud A.-S., Stoffler A., Mobius H.-J., Forette F. Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized placebo controlled trial (MMM 300). Stroke. 33:2002;1834-1839.
150. Moretti R., Torre P., Antonello R.M., Cazzato G. Rivastigmine in subcortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow-up. Eur J Neurol. 8:2001;361-362.
151. Erkinjuntti T., Kurtz A., Gauthier S., Bullock R., Lillenfeld S., Damaraju C.V. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet. 359:2002;1283-1290.
152. Pratt R., Perdomo C.A. Results of clinical studies with donepezil in vascular dementia. Am J Geriatr Psychiatry. 10:(suppl 1):2002;88-89.